Loading...

CURRENT TRENDS IN VACCINES AND VACCINOLOGY (ISSN:2631-8970)

About the Journal

Recently Published Articles

Review

Improving COVID-19 Vaccine Efficacy and Safety with Intradermal and Reduced-Dose Approaches

Corresponding Author: Sushil K. Mehandru, Jersey Shore University Medical Center, Chief of Nephrology, Professor of Medicine, Neptune, New Jersey, United States.
Pdf Full text Views (902)

Review

The Potential of Dry Powder Vaccines for Intranasal Immunization

Corresponding Author: Gerallt Williams, Aptar Pharma, France.
Pdf Full text Views (795)

Letter to Editor

Neurological Adverse Events Emerging in Covid-19 Vaccine Trial. Is Autoimmunity Involved?

Corresponding Author: Paolo Bellavite, Section of General Pathology University of Verona (I), Department of Medicine, Italy, Italy.
Pdf Full text Views (4521)

Original Article

Do Preterm Infants Present More Vaccine Adverse Events Than Full-Term Infants? A Cross-Sectional Study

Corresponding Author: Eduardo Jorge da Fonseca Lima, Professor of the Medical School at Faculdade Pernambucana de Saúde (FPS), Postgraduate latu sensu coordinator at Instituto de Medicina Integral Prof. Fernando Figueira (IMIP), Brazil.
Pdf Full text Views (1013)

Review Article

microRNA-Based Vaccination and Treatment for COVID-19

Corresponding Author: Hussein Sabit, Imam Abdulrahman Bin Faisal University, Department of Genetics Institute for Research and Medical Consultations (IRMC), Dammam, 31441, Saudi Arabia.
Pdf Full text Views (3820)

Editorial Team

The Current Trends in Vaccines and Vaccinology (CTVV) is an international, peer-reviewed, open access journal published by Boffin Access Limited. The journal is dedicated to advancing the science, technology, and clinical application of vaccines. It provides a trusted global platform for researchers, clinicians, immunologists, and public health experts to share innovations that enhance disease prevention and global health security.

Vaccinology has transformed modern medicine by controlling infectious diseases and preventing epidemics. With the rise of novel pathogens, pandemics, and the need for innovative immunization strategies, CTVV serves as a critical source of cutting-edge research, evidence-based practices, and policy insights.

Aims and Scope

CTVV publishes original research articles, reviews, case studies, short communications, perspectives, and clinical trial reports across diverse areas, including:

  • Vaccine design, development, and production technologies

  • Novel vaccine platforms (mRNA, DNA, viral vector, nanoparticle, peptide-based)

  • Adjuvants and immunomodulatory agents

  • Pediatric, maternal, and adult immunization programs

  • Cancer vaccines, therapeutic vaccines, and personalized immunization approaches

  • Vaccine safety, efficacy, and regulatory science

  • Global vaccination strategies and public health policies

  • Challenges in vaccine delivery, distribution, and equity

  • Antigen discovery and immune response mechanisms

  • Emerging infectious diseases and pandemic preparedness

  • Vaccinology in veterinary medicine and zoonotic diseases

Why Publish with CTVV?

  • High Relevance – Covers both basic research and applied vaccinology with global health implications.

  • Rigorous Peer Review – Double-blind review ensures academic integrity and reliability.

  • Rapid and Open Access – Accepted manuscripts are quickly published online for worldwide accessibility.

  • Global Readership – Widely disseminated to researchers, healthcare providers, policymakers, and vaccine developers.

  • Multidisciplinary Collaboration – Bridges immunology, biotechnology, clinical medicine, and public health.

  • Author Rights – Authors retain copyright under Creative Commons licensing, promoting maximum reuse and visibility.

  • Enhanced Formats – Articles may be published with supplementary datasets, clinical trial data, or multimedia.

Editorial & Ethical Standards

CTVV adheres to internationally recognized ethical guidelines, including COPE and ICMJE principles. The journal is committed to transparency, reproducibility, and responsible dissemination of scientific knowledge that impacts public health policies and practices.

Subjects covered by the Current Trends in Vaccines and Vaccinology

  • Active Immunization
  • Alzheimer's Disease Amyloid Protein Vaccine
  • Artificial Induction of Immunity
  • Caries Vaccine
  • Chikungunya Vaccine
  • Clinical Evaluation of Vaccines
  • COVID-19 Vaccine
  • Cytomegalovirus Vaccine
  • Dengue Vaccine for Humans
  • Dpt Vaccine
  • Ebola Vaccine
  • Enterovirus 71 Vaccine
  • Experimental Vaccines
  • Hib Vaccine
  • Hookworm Vaccine
  • HTLV-1 T-lymphotropicLeukemia Vaccine for Humans
  • Immunization
  • Inactivated Vaccines
  • Japanese Encephalitis Vaccine
  • Leprosy Vaccine
  • Lyme Disease Vaccine
  • Marburg Virus Disease Vaccine
  • MMR Vaccine
  • Non-Clinical Development of Vaccines
  • Norovirus Vaccine
  • Novel Vaccine Delivery
  • Ovarian Cancer Vaccine
  • Pneumococcal Conjugate Vaccine
  • Polio Vaccine
  • Preclinical Vaccine Studies
  • Q Fever Vaccine
  • Recombinant Vector Vaccines
  • Regulatory Science
  • Respiratory Syncytial Virus Vaccine
  • Schistosomiasis Vaccine
  • Smallpox Vaccine
  • Streptococcus Pyogenes Vaccine
  • Syphilis Vaccine
  • Tick-Borne Encephalitis Vaccine
  • Toxoids
  • Tuberculosis (BCG) Vaccine
  • Typhoid Vaccine
  • Vaccine Adjuvants and Conjugate Vaccines
  • Vaccine Design and Development
  • Vaccine Research &Development
  • Vaccine Trials
  • Vaccine-Preventable Diseases
  • Vaccines Epidemiology
  • West Nile Virus Vaccine for Humans
  • Yersinia Pestis Vaccine
  • Adenovirus Vaccine
  • Anthrax Vaccines
  • Cancer/Oncology Vaccines
  • Chagas Disease Vaccine
  • Cholera Vaccine
  • Conventional and Non-Conventional Vaccines
  • Coxsackie B Virus Vaccine
  • Dengue Vaccine
  • Diva Vaccines
  • Eastern Equine Encephalitis Virus Vaccine for Humans
  • Ehrlichiosis Vaccine
  • Epstein–Barr Vaccine
  • Hepatitis Vaccines
  • Hiv Vaccines Research & Development
  • Hpv Vaccine
  • Human Papilloma Virus Vaccine
  • Immunotherapeutics
  • Influenza Vaccine
  • LeishmaniasisVaccine
  • Live Attenuated Vaccines
  • Malaria Vaccine
  • Meningococcal Vaccine
  • Molecular Aspects of Vaccine Development
  • Non-Infectious Diseases
  • Novel Approaches In Vaccination And Immunotherapy
  • Onchocerciasis River Blindness Vaccine For Humans
  • Parasitic Diseases
  • Pneumococcal Polysaccharide Vaccine
  • Pre-Clinical &Clinical Testing of Vaccines
  • Prostate Cancer Vaccine
  • Rabies Vaccine
  • Regulatory Authorization of Vaccines
  • Research and Development of Novel Vaccines and Immunotherapeutics
  • Rotavirus Vaccine
  • Severe Acute Respiratory Syndrome (SARS) Vaccine
  • Staphylococcus Aureus Vaccine
  • Subunit Vaccines
  • Talimogenelaherparepvec (T-VEC)
  • Timeline of Vaccines
  • Trypanosomiasis Vaccine
  • TularemiaVaccine
  • Vaccination Strategies
  • Vaccine Components
  • Vaccine Formulation
  • Vaccine Safety
  • Vaccine-Induced Seropositivity
  • Vaccines Dermatology
  • Viral Vaccines
  • Yellow Fever Vaccine

Open Access Journals

Abstracting and Indexing

SCINEXI use Crossref Similarity Check for averting plagiarism

Retractions

SCINEXI is committed to upholding the integrity and credibility of the scholarly record. In accordance with international publishing ethics, articles may be retracted when found to contain serious errors, evidence of research misconduct, copyright infringement, or plagiarism. Retraction is a necessary step to safeguard academic reliability and to ensure that the literature remains a trustworthy resource for the global research community.

If you wish to report a concern regarding any published article, please share the details with us by clicking below:

Send Information

Subscribe to our Newsletter

Stay connected with SCINEXI. Enter your e-mail address to receive alerts on newly published articles, special issue announcements, and the latest updates from our journals.

Feedback

At SCINEXI, we actively welcome feedback and constructive criticism. Your compliments, concerns, and suggestions help us refine our services and elevate the author and reader experience.

Have an idea that could advance the Open Access community? We’d love to hear it. Please write to: support@scinexi.com